Global private equity and venture capital news and research

Posts Tagged ‘ARCH Venture Partners’

21 November 2016

Arch Venture Partners boosts Fund IX target after storming start to fundraise

ruin-1778575_1920 Arch Venture Partners has upped its sights for its latest venture fundraise after already passing the $400m it initially registered to raise, AltAssets can reveal.

25 April 2016

VC-backed Hua Medicine seals $50m Series C financing round

lump-sugar-549096_1920 Chinese diabetes and nervous system disorder therapy developer Hua Medicine has picked up a $50m venture capital-backed Series C round of financing.

18 March 2016

Arch Venture Partners primes new $400m fundraise

delicate-arch-4625_1920 Chicago-based early-stage investment firm Arch Venture Partners is back in the market targeting up to $400m for its ninth fund.

16 June 2015

Arch leads $30m in Aledade alongside return investor Venrock

spire healthcare Arch Venture Partners has led $30m Series B financing round in Aledade, a US company which looks to help doctors run small practices.

15 May 2015

Degenerative brain disease treatment company Denali launched with $217m VC backing

brain-001-880737-m A group of venture capital investors have helped launch degenerative brain disease treatment company Denali Therapeutics through a $217m investment.

15 April 2015

Company helping synthesise human vision nets $40m VC-backed funding round

eye A joint venture between Atlantic Bridge Capital and WestSummit Capital has led a $40m financing round for a tech business which aims to help companies implement visual sensing to mimic human sight.

12 March 2015

Kura Oncology closes $60m EcoR1 Capital-led round

download (76) EcoR1 Capital has led a $60m financing round in biopharmaceutical company in Kura Oncology.

22 December 2014

VC-backed Juno Therapeutics raises $264.5m at IPO

money-in-hand-1035691-m Arch Venture Partners-backed cancer fighting company Juno Therapeutics has raised $264.5m after pricing its shares at $24m.

28 October 2014

Syros lands $53m from eight VC firms

pills-pills-pills-4-606633-m Eight venture capital firms have participated in a $53m Series B financing round for gene control therapies company Syros Pharmaceuticals.

27 August 2014

Arch Venture Partners raises more than $400m for latest fund

chicagooo Chicago-based venture capital firm Arch Venture Partners has closed its eighth fund on more than $400m, easily beating its $250m target.

Page 1 of 3123

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016